Reply to: "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?"
- PMID: 33599004
- PMCID: PMC8013411
- DOI: 10.1002/mds.28482
Reply to: "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?"
Keywords: COVID-19; Parkinson's disease; aging; SARS-CoV-2; neurodegenerative disease.
Comment on
-
SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration.Mov Disord. 2020 May;35(5):716-720. doi: 10.1002/mds.28084. Epub 2020 Apr 24. Mov Disord. 2020. PMID: 32291797 Free PMC article. No abstract available.
-
Parkinson's Disease and COVID-19: Do We Need to Be More Patient?Mov Disord. 2021 Feb;36(2):277. doi: 10.1002/mds.28469. Mov Disord. 2021. PMID: 33599003 Free PMC article. No abstract available.
References
-
- Lippi A, Domingues R, Setz C, Outeiro TF, Krisko A. SARS‐CoV−2: at the crossroad between aging and neurodegeneration. Mov Disord 2020;35(5):716–720. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/mds.28084 - DOI - PMC - PubMed
-
- Domingues R, Lippi A, Setz C, Outeiro TF, Krisko A. SARS‐CoV‐2, immunosenescence and inflammaging: partners in the COVID‐19 crime. Aging 2020;12(18):18778–18789. Available from: https://www.aging-us.com/lookup/doi/10.18632/aging.103989. - DOI - PMC - PubMed
-
- Brundin P, Nath A, Beckham JD. Is COVID‐19 a perfect storm for Parkinson's disease? Trends Neurosci 2020;43(12):931–933. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0166223620302423 - PMC - PubMed
-
- Hoffman LA, Vilensky JA. Encephalitis lethargica: 100 years after the epidemic. Brain 2017;140(8):2246–2251. Available from: http://academic.oup.com/brain/article/140/8/2246/3970828 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
